Profile
LSB VRTX REGN ALNY SGEN ARGX
Company Name LakeShore Biopharma Co., Ltd Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. Seagen Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $22.71M $117.98B $60.26B $43.28B $43.15B $34.40B
Employees 0.76K 6.10K 15.16K 2.23K 3.26K 1.60K
CEO Wang Xu Reshma Kewalramani FASN, Leonard S. Schleifer Yvonne L. Greenstreet David R. Epstein Timothy Van Hauwermeiren EMBA,
Ratings
LSB VRTX REGN ALNY SGEN ARGX
Quant Rating Score 1 2 4 1 3 2
Quant Rating Strong Sell Sell Buy Strong Sell Neutral Sell
Trading
LSB VRTX REGN ALNY SGEN ARGX
Last Close $1.08 $468.85 $567.74 $314.94 $228.74 $560.24
High 52 $5.45 $516.74 $1201.76 $331.91 $228.74 $671.75
Low 52 $0.4 $396.64 $482.92 $224.58 $228.74 $461.01
Price vs. 52 Week High -80.18 % -9.27 % -52.76 % -5.11 % 0 % -16.6 %
Price vs. 52 Week Low 170 % 18.21 % 17.56 % 40.24 % 0 % 21.52 %
Total Return
LSB VRTX REGN ALNY SGEN ARGX
1 Month Return 9.1 % 1.91 % 8.81 % 3.37 % 0 % -4.52 %
3 Month Return -36.09 % -3.17 % 2.45 % 32.46 % 0 % -3.56 %
6 Month Return -64.94 % 14.48 % -18.53 % 32.34 % 0 % -14.63 %
9 Month Return -71.35 % -2.67 % -44.1 % 10.77 % 0 % 4.39 %
YTD Return -68.79 % 16.43 % -20.3 % 33.84 % 0 % -8.9 %
1 Year Return 129.64 % -4.07 % -48.39 % 20.89 % 0 % 20.11 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
LSB VRTX REGN ALNY SGEN ARGX
Dividend Yield Percentage (TTM) - - 0.31 % - - -
Dividend Paid and Capex Coverage Ration (TTM) - -3.53 % 3.85 % -1.49 % -5.87 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Growth
LSB VRTX REGN ALNY SGEN ARGX
Asset Growth -12.02 % -0.87 % 36.55 %
Gross Profit Growth -14.63 % 10.25 % 77.08 %
Revenue Growth -16.56 % 11.66 % 78.6 %
Revenue 3 Year -40.01 % 45.6 % 275.84 %
Revenue 5 Year -40.01 % 163.93 % 1701.04 %
Revenue 10 Year -40.01 % 1632.15 % 5950.81 %
EBIT Growth -262.02 % -93.69 % 128.87 %
Net Income Growth -197.96 % -114.8 % 382.34 %
Net Income 3 Yeari Growth Per Share 39.24 % -122.89 % 274.39 %
Net Income 5 Yeari Growth Per Share 39.24 % -145.38 % 396.61 %
Net Income 10 Yeari Growth Per Share 39.24 % 33.84 % 938.02 %
Operating Income Growth -219.86 % -106.08 % 94.91 %
Operating Cash Flow Growth (CFG) -61.8 % -113.93 % 80.31 %
Operating 3 Year CFG 67.81 % -118.65 % 88.36 %
Operating 5 Year CFG 67.81 % -131.3 % -135.21 %
Operating 10 Year CFG 67.81 % 12.43 % -64 %
EPS Growth -115.43 % -114.8 % 369.77 %
EPS Diluted Growth -115.43 % -114.97 % 347.67 %
Book Value Per Share -41.83 % -6.59 % 28.16 %
Share Holder 3 Year Equity Growth Per Share 736433.74 % 62.6 % 85.14 %
Share Holder 5 Year Equity Growth Per Share 736433.74 % 168.85 % 200.53 %
Share Holder 10 Year Equity Growth Per Share 736433.74 % 1265.7 % 1039.11 %
Dividend Per Share Growth - - -
Dividend 3 Year Growth Per Share - - -
Dividend 5 Year Growth Per Share - - -
Dividend 10 Year Growth Per Share - - -
Debt Growth -14.87 % 116.42 % 95.27 %
Free Cash Flow Growth -41.73 % -124.1 % 67.46 %
Updated On 31 Mar 2024 31 Dec 2024 31 Dec 2024
Profitability
LSB VRTX REGN ALNY SGEN ARGX
Gross Profit Margin TTM 55.29 % 86.03 % 84.94 % 86.01 % 79.1 % 46.33 %
Return on Assets TTM -17.29 % -4.32 % 11.98 % -6.4 % -16.61 % 13.45 %
Return on Equity TTM -49.36 % -6.25 % 14.77 % -509.33 % -20.8 % 16.83 %
Return on Capital Employed TTM -37.32 % -3.89 % 11.35 % -3.68 % -21.46 % -0.5 %
Net Income Per EBT TTM 92.59 % 329.41 % 90.27 % 75.89 % 101.33 % 25990.14 %
EBT Per Ebit TTM 106.48 % 40.44 % 129.3 % 308.03 % 98.26 % -11.64 %
EBIT Per Revenue TTM -87.2 % -6.69 % 27.37 % -4.91 % -31.24 % -1.24 %
Cash Flow To Debt Ratio TTM - -59.44 % 146.15 % -3.47 % -1043.73 % -201.37 %
Receivables Turnover TTM 0.68 6.15 2.53 5.62 3.91 2.46
Payables Turnover TTM 2.01 3.49 3.01 3.37 1.97 2.39
Inventory Turnover TTM 0.66 1.14 0.66 5.01 0.96 2.93
Fixed Asset Turnover TTM 63.3 % 421.34 % 300.07 % 337.41 % 665.41 % 4929.48 %
Asset Turnover TTM 20.11 % 48.51 % 37.52 % 55.72 % 53.41 % 35.83 %
Operating Cash Flow Per Share TTM - -3.82 37.05 -0.35 -2.46 -1.07
Free Cash Flow Per Share TTM - -4.9 28.3 -0.58 -2.88 -1.09
Cash Per Share TTM 1658.73 % 2413.86 % 7825.12 % 2024.29 % 939.52 % 4688.94 %
Operating Cash Flow Sales Ratio TTM - -8.83 % 28.06 % -1.92 % -23.12 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM - 128.33 % 76.4 % 167.11 % 117.04 % 102.26 %
Cash Flow Coverage Ratios TTM - -59.44 % 146.15 % -3.47 % -1043.73 % -201.37 %
Price To Free Cash Flows Ratio TTM - -93.78 19.95 -574.08 -81.26 -443.33
Price To Operating Cash Flows Ratio TTM - -120.39 15.32 -954.11 -93.1 -526.76
Price Cash Flow Ratio TTM - -120.39 15.32 -954.11 -93.1 -526.76
Income Statement (TTM)
LSB VRTX REGN ALNY SGEN ARGX
Revenue $0.57B $11.02B $14.2B $2.25B $1.96B $2.19B
Gross Profit $0.46B $9.49B $12.23B $1.92B $1.55B $1.96B
Gross Profit Ratio 79.48% 86.11% 86.13% 85.62% 79.1% 89.62%
EBITDA $-0.37B $0.49B $5.32B $-0.18B $-0.62B $0.11B
Net Income $-0.43B $-0.54B $4.41B $-0.28B $-0.61B $0.83B
EPS Diluted -4.05 -2.08 38.34 -2.16 -3.3 12.78
Balance Sheet (MRQ)
LSB VRTX REGN ALNY SGEN ARGX
Long Term Debt $0.1B $1.66B $1.98B $0B $0.04B $0.03B
Total Liabilities $0.93B $6.12B $8.41B $4.17B $0.87B $0.7B
Total Equity $0.59B $16.41B $29.35B $0.07B $2.8B $5.5B
Total Investments $0B $6.65B $15.42B $1.73B $1.42B $1.93B
Total Debt $0.42B $1.75B $2.7B $1.3B $0.04B $0.04B
Total Assets $1.51B $22.53B $37.76B $4.3B $3.67B $6.2B
Cash Flow Statement (TTM)
LSB VRTX REGN ALNY SGEN ARGX
Net Income $-0.43B $-0.54B $4.41B $-0.28B $-0.61B $-0.02B
Inventory $-0.09B $-0.52B $-0.62B $0.01B $-0.23B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.3B $-0.49B $4.42B $-0.01B $-0.45B $-0.08B
Capital Expenditure $-0.04B $-0.3B $-0.76B $-0.03B $-0.08B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 38.24
AARD Aardvark Therapeutics, Inc. Common Stock 12.17
ABCL AbCellera Biologics Inc. 4.01
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.74
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.4
ABPWW 0.0351
ABSI Absci Corporation 2.67
ABUS Arbutus Biopharma Corporation 3.17
ABVC ABVC BioPharma, Inc. 3.97
ABVX Abivax SA American Depositary Shares 8.27
ACAD ACADIA Pharmaceuticals Inc. 20.98
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.7495
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.32
ACIU AC Immune SA 2.04
Unlock